Also at your disposal are a number of useful links, which will take you to guidelines on fluid management along with other relevant sites.
European Association for the Study of the Liver (EASL) clinical practice guidelines on the management of decompensated cirrhosis, including ascites, spontaneous bacterial peritonitis (SBP), and hepatorenal syndrome in cirrhosis are available (European Association for the Study of the Liver, 2018).
The progression from compensated to decompensated cirrhosis is marked by numerous overt clinical signs such as ascites, bleeding, encephalopathy, and jaundice. The progression of the disease and the associated complications can reduce median survival from 12 years to approximately 2 years. The need for effective management of these symptoms has led the European Association for the Study of the Liver to publish their first Clinical Practice Guidelines for the management of decompensated cirrhosis. The recommendation of albumin infusion is seen across the guidelines for a number of the complications discussed. This infographic highlights the role of albumin has in managing the signs and symptoms of decompensated cirrhosis.
This section of the Fluid Management Learning Zone provides links to external sites, where you will be able to further your knowledge of fluid management to provide your patients with the most appropriate treatment option.
An asymptomatic compensated phase followed by a decompensated phase characterises the natural history of cirrhosis. It is also marked by the development of overt clinical signs. The most frequent of which are ascites, bleeding, encephalopathy, and jaundice. See the Clinical Practice Guideline.